Literature DB >> 1486441

Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer.

J L McCall1, J A Tuckey, B R Parry.   

Abstract

Cancer cachexia may be mediated by endogenous peptides such as tumour necrosis factor alpha (TNF-alpha). Insulin resistance occurs in these patients, and is also seen experimentally with TNF-alpha administration. In this study, insulin sensitivity and energy metabolism were measured in 11 patients with gastrointestinal cancer and ten controls, using the euglycaemic glucose clamp and indirect calorimetry. Patients with cancer were significantly more insulin resistant than controls (P < 0.01) and in such patients insulin resistance correlated with serum TNF-alpha level (rs = 0.74, P < 0.01). Fasting insulin levels also correlated inversely with insulin sensitivity (rs = -0.62, P = 0.003). These results suggest a possible association between endogenous TNF-alpha production and insulin resistance in patients with gastrointestinal cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486441     DOI: 10.1002/bjs.1800791240

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model.

Authors:  Si-Zeng Chen; Jian-Dong Xiao
Journal:  Tumour Biol       Date:  2014-01

2.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

Authors:  G S Hotamisligil; D L Murray; L N Choy; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

3.  Is there a role for carbohydrate restriction in the treatment and prevention of cancer?

Authors:  Rainer J Klement; Ulrike Kämmerer
Journal:  Nutr Metab (Lond)       Date:  2011-10-26       Impact factor: 4.169

4.  ROS constitute a convergence nexus in the development of IGF1 resistance and impaired wound healing in a rat model of type 2 diabetes.

Authors:  Milad S Bitar; Fahd Al-Mulla
Journal:  Dis Model Mech       Date:  2012-02-23       Impact factor: 5.758

Review 5.  Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians.

Authors:  Hiroshi Noto; Tetsuro Tsujimoto; Mitsuhiko Noda
Journal:  J Diabetes Investig       Date:  2012-02-20       Impact factor: 4.232

Review 6.  Latest insights into the risk of cancer in diabetes.

Authors:  Hiroshi Noto; Atsushi Goto; Tetsuro Tsujimoto; Keiichiro Osame; Mitsuhiko Noda
Journal:  J Diabetes Investig       Date:  2013-05-06       Impact factor: 4.232

Review 7.  Restricting carbohydrates to fight head and neck cancer-is this realistic?

Authors:  Rainer J Klement
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

Review 8.  Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.

Authors:  R J Klement; M K Fink
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

Review 9.  Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism.

Authors:  Qianying Zuo; Nicole Hwajin Park; Jenna Kathryn Lee; Zeynep Madak Erdogan
Journal:  Nutrients       Date:  2022-06-08       Impact factor: 6.706

10.  The evaluation of the role of beta-hydroxy fatty acids on chronic inflammation and insulin resistance.

Authors:  A S Soydan; H S Dokmetas; M Cetin; A Koyuncu; E Kaptanoglu; H Elden
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.